Carvedilol

ADVERTISEMENT

Identification

Molecular formula
C24H26N2O4
CAS Number
72956-09-3
IUPAC Name
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone
Molecular Weight
406.48g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1651g/cm3
Synonyms
doxazosin
Interesting facts

Interesting Facts about [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone

This fascinating compound, often referred to in scientific literature for its diverse biological activities, is a prime example of how intricate molecular designs can lead to significant therapeutic potentials. Here are some notable facts:

  • Pharmacological Potential: The compound encompasses a quinazoline moiety, which is a well-known structure in medicinal chemistry. Compounds containing quinazoline derivatives have been reported to exhibit various pharmacological properties, including anticancer, antimicrobial, and anti-inflammatory actions.
  • Piperazine Linkage: The inclusion of a piperazine ring enhances its pharmacokinetic profiles, making it a vital component in many pharmaceuticals. Piperazines are recognized for their ability to interact with various neurotransmitter receptors, influencing mood and cognitive function.
  • Structure-Activity Relationship (SAR): Its complex structure allows for extensive SAR studies that can lead to the development of more effective analogs. The substitution patterns on the quinazoline and benzodioxin portions can provide insights into modifying activity and selectivity against biological targets.
  • Potential Use in Cancer Therapy: Research indicates that compounds with similar structural components have shown promising results in inhibiting tumor growth and proliferation. This positions our compound as a candidate for further preclinical and clinical studies.
  • Multi-Target Approach: The unique combination of various pharmacophores suggests that this compound may act on multiple biological pathways, making it a significant subject of interest in drug development for polypharmacy approaches in treating complex diseases.

Scientific exploration into [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone aids in enhancing our understanding of how modifications to molecular frameworks can lead to novel therapeutic agents. As researchers continue to dissect its properties, the future may hold even more astonishing discoveries regarding its application in modern medicine.

ADVERTISEMENT